ENDOCRINE Flashcards
ANTIDIURETIC HORMONES
DIABETES INSIPIDUS
EXCESS DILUTE URINE=?
EXTREME THIRST
NORMAL PERSON? ADH, hypothalamus
Hypothalamus produces vasporessin (ADH)->stored in pituitary gland
ADH released when water in the body becomes too low
ADH retains water in the body by reducing amount of water lost through the kidneys
Therefore, more CONCENTRATED urine
DIABETES INSIPIDUS?
Reduced production of ADH
Kidneys do NOT retain much water, so too much water passed from body
Causing extreme thirst/polyuria
Therefore, more DILUTE urine
2 TYPES OF DIABETS INSIPIDUS?
PITUITARY (CRANIAL)- lack of ADH production
NEPHROGENIC (PARTIAL)- NO response to ADH
DIABETES INSIPIDUS
PITUITARY (CRANIAL) TREATMENT?
VASOPRESSIN/DESMOPRESSIN
DIABETES INSIPIDUS
NEPRHOGENIC (PARTIAL) TREATMENT?
THIAZIDE-DIURETIC (paradoxical effect)
HOW DOES THIS WORK? UNDERSTANDING!
DESMOPRESSIN x3 FEATUERS?
More potent+longer duration of action than vasopressin
No vasoconstrictor effect->avoid bp conditions?
DESMOPRESSIN- SIDE-EFFECTS?
Hyponatraemia
Nausea
INAPPROPRIATE ADH SECRETION
Hyponatraemia explained?
Increased ADH-> body stores too much water-> dilutes the salt conc. in the blood-> hyponatraemia
HYPONATRAEMIA TREATMENT? FDT
FLUID RESTRICTION
DEMECLOCYCLINE (blocks renal tubular effect of ADH)
TOLVAPTAN (vasopressin antagonist)
Why do we AVOID rapid correction of hyponatraemia w/ Tolvaptan?
Causes osmotic demyelination-> serious neurological events
CORTICOSTEROIDS
2 TYPES?
MINERALCORTICOIDS
GLUCOCORTICOIDS
x2 FEATURES OF MINERALCORTICOID STEROIDS? Bottle of water
HIGH FLUID retention
LOW anti-inflammatory effect
MINERALCORTICOID STEROID ACTIVITY? high to low
FLUDROCORTISONE
HYDROCORTISONE
FLUDROCORTISONE ALSO USED TO TREAT?
POSTURAL HYPOTENSION
MINERALCORTICOID SIDE-EFFECTS?
Oedema
Hypertension-> soidum+water retention
Potassium loss-> hypokalaemia
Calcium loss-> hypocalcaemia
Mineralocorticoid actions are negligible with the high potency…? GBD
GLUCOCORTICOIDS
BETAMETHASONE
DEXAMETHASONE
X2 FEATURES OF GLUCORTICOID STEROIDS?
HIGH ANTI-INFLAMMATORY EFFECT
LOW FLUID RETENTION
HIGHEST GLUCOCORTICOID STEROID ACTIVITY?
DEXAMETHASONE/BETAMETHASONE
GLUCOCORTCOID SIDE-EFFECTS? DOAG
DIABETES
OSTEROPOROSIS-> fractures
AVASCULAR NECROSIS OF FEMORAL HEAD+ MUSCLE WASTING
GASTRIC ULCERATION+PERFORATION
Clopi+Lans, NOT Omep
CORTICOSTEROID SIDE-EFFECTS? MHRA
CENTRAL SEROUS CHORIORETINOPATHY->report blurred vision/other visual disturbances
CORTICOSTEROID PSYCHIATRIC REACTIONS?
INSOMNIA, IRRITABILITY, MOOD CHANGE, ETC
SEEK ADVICE+STOP TEATMENT
STEROID EMERGENCY CARD? For patients with…
ADRENAL INSUFFICIENCY STEROID DEPENDENCE (risk of adrenal crisis)
CORTCOISTEROID SIDE-EFFECTS
ADRENAL SUPPRESSION?
Prolonged use can lead to adrenal atrophy (years)
DON’T STOP ABRUPTLY (acute adrenal insufficiency/hypotension/death)
Significant illness/trauma/surgery-> temporary increase in corticosteroid dose OR temporary reintroduction if already stopped
CORTICOSTEROID SIDE-EFFECTS? I->CM
INFECTIONS (immunocompromised, can’t clock on)
|
CHICKEN POX-> passive immunisation w/ varicella-zoster immunoglobin if unimmune (+if taken steroid in past 3 months)
|
MEASLES-> prophylaxis w/ IM normal immunoglobulin if needed
CORTICOSTEROID SIDE-EFFECTS? ICS
INSOMNIA-> take OM (cortisol produced then)
CHILDREN-> stunted growth, even w/ inhaled
SKIN THINNING-> most common in topical (apply thinly!)
CORTICOSTEROID PROLONGED USE SIDE-EFFECT?
Manage?
Treat?
CUSHING'S SYNDROME | Moon face/striae/hirsutism/acne | Manage? w/ Metyrapone Treat? w/ Ketoconazole
CORTICOSTEROID SIDE-EFFECTS ROUND UP C O R T I C O S t E R O I D u S e
Cushing's Osteroporosis Retardation of growth Thin skin Immunocompromised+Insomnia Chorioretinopathy Oedema (water retention) Striae T? Emotional Rise in BP (Hypertension) Obestity (truncal) Increased hair growth (hirsutism) Diabetes mellitus (hyperglycaemia) u SUPPRESSION (adrenal) Electrolyte imbalance (hypokalaemia
HOW DO WE MANAGE STEROID SIDE-EFFECTS?
LOWEST EFFECTIVE DOSE, MINIMUM PERIOD SINGLE DOSE OM 2 DAYS DOSE? GIVE ON ALTERNATE DAYS SHORT COURSES? INTERMITTENT THERAPY LOCAL>SYSTEMIC e.g. creams, inhalations, eye-drops, enemas
WHEN DO YOU GRADUALLY WITHDRAW FROM STEROIDS?
GIVE ALL?
> 40MG PREDNISOLONE FOR >1 WEEK
REPEAT EVENING DOSES
> 3 WEEKS TREATMENT, ANY DOSE
RECEIVED RECEIVED REPEATED COURSES/TAKEN SHOURT COURSE WITHIN 1 YEAR OF STOPPING LONG-TERM THERAPY
OTHER CAUSES OF ADRENAL SUPPRESSION
GIVE ALL? STEROID CARD
TOPIC STEROID POTENCIES
MILD?
MODERATE?
POTENT?
VERY POTENT?
MILD? Hydrocortisone
MODERATE? Clobetasone
POTENT? Betamethasone
VERY POTENT? Clobetasol
WHAT IS ADRENAL INSUFFICIENCY CAUSED BY?
ADDISON’S DISEASE
CONGENITAL ADRENAL HYPERPLASIA
ADRENAL INSUFFICIENCY TREATMENT?
PRIMARY?
TREAT WITH HYDROCORTISONE
PRIMARY? +FLUDROCORTISONE (mineralcorticoid replacement- aldosterone deficiency)
ADRENAL INSUFFICIENCY CAN LEAD TO…?
ADRENAL CRISIS
SYMPTOMS OF ADRENAL CRISIS? SHAS^2 CD
SHAS^2 CD SEVERE DEHYDRATION HYPOVOLAEMIC SHOCK ALTERED CONSCIOUSNESS SEIZURES STROKE CARDIAC ARREST | DEATH
ADRENAL CRISIS TREATMENT?
hydrocortisone+Rehydration using a crystalloid fluid (e.g. sodium chloride 0.9%).
For patients usually on fludrocortisone, high-dose hydrocortisone has sufficient mineralocorticoid effect to cover this
DIABETES MELLITUS is…?
PERSISTENT HYPERGLYCAEMIA
DIABETES CAN BE CAUSED BY…?
DEFICIENT INSULIN SECRETION (TYPE 10
RESISTANCE TO ACTION OF INSULIN (TYPE 2)
PREGNANCY (GESTATIONAL)
MEDICATIONS (SECONDARY) e.g. STEROIDS!
DIABETES MELLITUS- DRIVING
All drivers w/ insulin must notify the DVLA.
What is awareness of hypoglycaemia?
The capability of bringing their vehicle to a safe controlled stop
GROUP 1 DRIVERS?
ADEQUATE AWARENESS OF HYPOGLYCAEMIA
NO MORE THAN 1 EPISODE OF SEVERE HYPOGLYCAEMIA WHILST AWAKE IN THE PRECEDING 12 MONTHS
GROUP 2 DRIVERS? (HGV, bus, etc)
FULL AWARENESS OF HYPOGLYCEAMIA
MUST REPORT ALL EPISODES, INCLUDING IN SLEEP
NO EPISODES OF SEVERE HYPOGLYCAEMIA IN THE PRECEDIG 12 MONTHS
MUST USE A BG meter with sufficient memory- store 3 months of readings
VUSUAL COMPLICATIONS- holla DVLA+do not drive
ADVICE FROM THE DVLA?
<5?
<4?
Insulin treatment? Carry a GM+BGS
Check BGC no >2hrs before driving+/2hours whilst driving
B-G should always be>5mmol/L whilst driving
<5mmol/L? Lickle snack
Ensure supply of FAST-ACTING carb in the whip
<5? lickle snack
<4? stop the whip
wait until 45 minutes after blood-glucose has returned to normal, before continuing journey
HYPOGLYCEAMIA WHILST DRIVING?
<4mmol/L
SAFELY STOP VEHICLE
OFF THE ENGINE, REMOVE KEYS FROM IGNITIONS, MOVE FROM DRIVER’S SEAT
EAT/DRINK SUITABLE SOURCE OF SUGAR
WAIT TILL 45MINS AFTER B-G BACK TONORMAL
DO NOT DRIVE IF HYPOGLYCAEMIA AWARENESS L+NOTIFY DVLA
TPYE 1 DIABETES
INSULIN DEFICIENCY?
DESTRUCTION OF INSULIN-PRODUCING BETA-CELLS IN THE PANCREATIC ISLETS OF LANGERHANS
Most common before adulthood
FEATURES OF TYPE 1 DIABETES?
HYPERGLYCAEMIA (>11mmol/L) KETOSIS RAPID WEIGHT LOSS BMI<25 AGE<50 FAMILY HISTORY OF AUTOIMMUNE DISEASE
TYPE 1 DIABETES- BLOOD GLUCOSE MONITORING
HOW MANY TIMES?
MONITOR AT LEAST 4 TIMES A DAY (including before each meal+before bed)
TYPE 1 DIABETES- BLOOD GLUCOSE MONITORING
TARGETS?
5-7 mmol/L on WAKING (fasting)
4-7 mmol/L fasting BG BEFORE meals at other times of the day
5-9 mmol/L 90mins AFTER eating
>5 mmol/L when driving
TYPE 1 DIABETES- INSULIN REGIMENS
HOW MANY TYPES?
MULTIPLE DAILY INJECTION BASAL-BOLUS (1st LINE)
BIPHASIC (mixture)
CONTINUOUS SC INFUSION (insulin pump)
TYPE 1 DIABETES- MULTIPLE DAILY INJECTION BASAL-BOLUS REGIMEN
BASAL?
AND
BOLUS?
BASAL (long/intermediate acting) OD or BD AND BOLUS (short/rapid acting) before meals
BASAL
1st LINE?
2nd LINE?
1st LINE? Insulin detemir BD
2nd LINE? Insulin glargine OD
TYPE 1 DIABETES- BIPHASIC MIXTURES?
SHORT-ACTING mixed with INTERMEDIATE insulin injected 1-3 TIMES A DAY
TYPE 1 DIABETES- CONTINOUS SC INFUSION (insulin pump) for..?
Adults who suffer w/ disabling hypoglycaemia/uncontrolled hyperglycaemia
WHAT FACTORS INCREASE INSULIN REQUIREMENTS? SIT DOWN BRO!
IST
Infection
Stress
Trauma
WHAT FACTORS DECREASE INSULIN REQUIREMENTS? EIRIE
EIRIE Exercise Intercurrent illness Reduced food intake Impaired renal function Endocrine disorders (thyroid, coeliac, addison's)
INSULIN ADMINISTRATION ADVICE?
Inactivated by GI enzymes- so SC
Injected into body area with plenty of SC fat:
abdomen (fast)
outer thighs/buttocks (slow)
Rotate injection sites: Lipohypertrophy happens due to repeato injection sites into same suto area Cutaneous amyloidosis (amyloid protein under skin)
2 TYPES OF SHORT-ACTING INSULIN?
SOLUBLE
RAPID-ACTING
SHORT-ACTING- SOLUBLE INSULIN
EXAMPLE?
INJECT?
ONSET?
DURATION?
EXAMPLE? HUMAN+BOVINE/PORCINE
INJECT? 15-30mins BEFORE MEALS
ONSET? 30-60mis, peak 1-4hrs
DURATION? Up to 9hrs
SHORT-ACTING- RAPID-ACTING INSULIN
NO LAGing
EXAMPLE?
INJECT?
ONSET?
DURATION?
EXAMPLE? Lispror/Aspart/Glulisine
INJECT? Immediately before meal
ONSET? <15mins (NO LAG!)
DURATION? 2-5hrs
INTERMEDIATE-ACTING INSULIN/BIPHASIC
EXAMPLE?
ONSET?
DURATION?
EXAMPLE? Biphasic isophane/biphasic aspart/biphasic lispro (isophane mixed with SA)
ONSET? 1-2hr, peak 3-12hrs
DURATION? 11-24hrs
LONG-ACTING INSULIN DDG EXAMPLE? INJECT? ONSET? DURATION?
DDG
EXAMPLE? Detemir/Degludec/Glargine
INJECT? OD (Detemir= BD)
ONSET? 2-4days to reach steady state
DURATION? 36hrs
TYPE 2 DIABETES is characterised by…?
Insulin resistance, later in life
Prediabetic HBA1c?
42-47mmol/mol
Can try prevent diabetes with lifestyle advice
Diabetes HbA1c?
48mmol/mol
DIABETES TREATMENT- LOW CVD RISK
What do you need to assess first?
HbA1c
Kidney function
Cardiovascular risk
ALL INDIIVDUALLY AGREED THRESHOLDS!
DIABETES TREATMENT- LOW CVD RISK
1st LINE?
METFORMIN
DIABETES TREATMENT- LOW CVD RISK
Metformin L,
HBA1C> individually agreed threshold?
DUAL THERAPY ADD IN... DPP-4i (gliptin) OR Pioglitazone OR SU (Sulphonylurea- glic, glim, tolb) OR SGLT-2i (Flozins)
DIABETES TREATMENT- LOW CVD RISK
DUAL THERAPY L..
HBA1C> individually agreed threshold?
TRIPLE THERAPY by... adding/swapping class of anti-diabetic
NOTE: DAPAG with PIOG not recommended, OTHER SGLT-2is calm
DIABETES TREATMENT- HIGH CVD RISK
When is it high risk?
Established atherosclerotic CVD
HF
QRISK2>10%
DIABETES TREATMENT- HIGH CVD RISK
1ST LINE?
ONCE TOLERATED?
IF NOT TOLERATED?
1ST LINE? METFORMIN
ONCE TOLERATED? ADD SLGT-2i
IF NOT TOLERATED? ALONE SLGT-2i
DIABETES TREATMENT- HIGH CVD RISK
HBA1C> individually agreed threshold?
SAME AS DUAL+TRIPLE THERAPY FLASHCARDS!
Patient w/ diabetes develops high risk CVD?
Consider SLGT-2i first.
EU marketing agency, recent approval for flozins in HF, draining effect. Lotta hype!
TREATMENT OF DIABETES- METFORMIN RESISTANCE
Patient can’t tolerate metformin due to side-effects?
Use MR preparations
TREATMENT OF DIABETES- METFORMIN RESISTANCE
Patient can’t tolerate metformin MR? Treat w/…
BUT
When high risk of CVD?
Treat w/ DPP-4I/Pioglitazone/SU/SLGLT-2I
(SU first choice heeh)
BUT
When high risk of CVD? SGLT-2i
TREATMENT OF DIABETES- METFORMIN RESISTANCE
HbA1c above individually agreed threshold& Monotherapy an L?
Treat w/…
Treat w/... DPP-4i+Piogltiazone OR DPP-4i+SU OR Pioglitazone+SU
TREATMENT OF DIABETES- METFORMIN RESISTANCE
HbA1c STILL not controlled..?
INSULIN THERAPY!
METFORMIN (biguanide)
MOA?
Decreases gluconeogenesis+increases peripheral utilisation of glucose
mad
METFORMIN SIDE-EFFECTS? LGV
LGV
Lactic acidosis (avoid if eGFR<30)
GI side-effects (increase dose slowly/give MR prep)
Can reduce vitamin B12
PATIENT ON METFORMIN w/ AKI?
STOP!
SULPHONYLUREAS
MOA?
S for secretion!
STILMULATES insulin secretio
SULPHONYLUREAS
MOA?
Stimulates insulin secretion from pancreatic beta cell
2 TYPES OF SULPHONYLUREAS?
SHORT-ACTING- GT- gliclazide, tolbutamide, glipizide
LONG-ACTING- GG- glibenclamide, glimepiride
What is LONG-ACTING sulphonylureas associated with?
Associated with prolonged/sometimes fatal cases of hypoglycaemia
AVOID IN ELDERLY
SULPHONYLUREAS- SIDE-EFFECTS? AH(R)F, not KHF
High risk of hypoglycaemia AVOID in: Acute porphyria (GTGTGTGTGTGTGTGT) Hepatic/Renal FAILURE
PIOGLITAZONE
MOA?
P for less peripheral!
Reduces peripheral insulin resistance
PIOGLITAZONE
AVOID IN…?
Patients with history of HF
PIOGLTAZONE
There’s an increase risk of…?
Report what..?
-Bladder cancer
review safety+efficacy after 3-6months
stop treatment if patient responds inadequately
REPORT…
Haematuria (blood in urine)
Dysuria (painful urination)
Urinary urgency
PIOGLITAZONE
Increase risk of…? continued
BONE FRACTURES
LIVER TOXICITY- report N&V, abdominal pain, fatigue & dark urine
PIOGLITAZONE IS MOSTLY ASSOCIATED WITH... HF BLADDER CANCER BONE FRACTURES LIVER TOXICITY
DPP-4i
MOA?
increases one, decreases the other
Increases insulin secretion+lowers glucagon secretion
DPP-4i
Can cause..?
Pancreatitis
Discontinue if symptoms of acute pancreatitis occur…
- persistent, severe abdominal pain
DPP-4i EXAMPLES?
ALLOGLIPTIN LINAGLIPTIN SAXAGLIPTIN SITAGLIPTIN VILDAGLIPTIN (hepatotoxic)
SLGT-2iS
MOA?
Inhibits SLGT2 in renal proximal convoluted tubule (more urine, glucose, infection)
SGLT-2iS
MHRA WARNINGS? DKAKFaGLLA
MONITOR RENAL FUNCTION!
DIABETIC KETOACIDOSIS
MONITOR KETONES if treatment interruped-> surgery/illness
FOURNIER’S GANGRENE
CANAGLIFLOZIN only: risk of lower-limb amputation (mainly toes)
SGLT-2iS
Volume depletion?
Due to lots of urination, loss of water
Correct hypovolaemia (reduced volume of circulating blood in body) before starting treatment
SGLT-2iS EXAMPLES?
CANAGLIFLOZIN
DAPAGLIFLOZIN
EMPAGLIFLOZIN
GLP-1 AGONIST
MOA?
GLP-1 receptor
BINDS TO GLP-1 RECEPTOR
Increases insulin secretion,
suppresses glucagon secretion
slows gastric emptying
GLP-1 AGONIST
EXAMPLES? -tides
DULAGLUTIDE
EXENATIDE
LIRAGLUTIDE
LIXISENATIDE
GLP-1 AGONIST SIDE-EFFECTS?
DULAGLUTIDE!!!
ACUTE PANCREATITIS- persistent, severe abdominal pain
DEHYDRATION- risk, due to GI side-effects, take precautions to avoid fluid depletion?
OTHER ANTIDIABETICS
ACARBOSE?
Delays digestion+absorption of starch+sucrose
Risk of GI side-effects- reduce dose?
OTHER ANTIDIABETICS
MEGLITIDES (Nataglinide/Repaglinide)?
Stimulates insulin secretion
Stressed? Change to treatment to insulin to maintain glycaemia control? :/
DIABETICS, PANCREATITIS ASSOCIATION? G^2
GLIPTINS
GLP-1 AGONIST, -tides-> PERSISTENT, ABDOMINAL SEVERE PAIN
ANTIDIABETIC EFFECT ON WEIGHT
WEIGHT GAIN?
NEUTRAL?
WEIGHT LOSS?
WEIGHT GAIN? Pioglitazone+Sulphonylureas+Insulin
NEUTRAL? Metformin+DPP-4i
WEIGHT LOSS? GLP-1+SGLT-2i
DIABETIC COMPLICATIONS
CARDIOVASCULAR DISEASE? Diabetes strong rf
WHAT DRUG IS CONSIDERED IN ALL TYPE 1 PATIENTS?
WHAT DRUG REDUCES CVD RISK?
WHAT DRUG IS CONSIDERED IN ALL TYPE 1 PATIENTS? Low-dose atorvastatin, offer to:
40+years
diabetic 10+years
nephropathy/other CVD factors
WHAT DRUG REDUCES CVD RISK?
ACEi, regardless of ethnicity
DIABETIC COMPLICATIONS
DIABETIC NEPHROPATHY, proteinuria (protein in urine)
TREATMENT?
WHAT DRUG CAN POTENTIATE HYPOGLYCAEMIA EFFECT OF ANTIDIABETIC DRUGS/INSULIN?
DIABETIC NEPHROPATHY, proteinuria (protein in urine)
TREATMENT? ACE-i/ARB
WHAT DRUG CAN POTENTIATE HYPOGLYCAEMIA EFFECT OF ANTIDIABETIC DRUGS/INSULIN? ACE-i (risk of HYPERkalaemia)
DIABETIC COMPLICATIONS
DIABETIC NEUROPATHY TREATMENTS
PAINFUL PERIPHERAL NEUROPATHY?
Diabetic foot?
AUTONOMIC NEUROPATHY?
NEUROPATHIC POSTURAL HYPOTENSION?
GUSTATORY SWEATING?
ERECTILE DYSFUNCTION?
VISUAL IMPAIRMENT?
PAINFUL PERIPHERAL NEUROPATHY? antidepressants/gabapentin/pregabalin
Diabetic foot? treat pain+manage infection
AUTONOMIC NEUROPATHY? treat diarrhoea w/ codeine/tetracyclines
NEUROPATHIC POSTURAL HYPOTENSION? increase salt intake/fludrocortisone
GUSTATORY SWEATING? antimuscarinic- propantheline bromide
ERECTILE DYSFUNCTION? Sildenafil
VISUAL IMPAIRMENT? Yearly eye tests
DIABETEIC KETOACIDOSIS- SEVERE HYPERGLYCAEMIA
SYMPTOMS? PTP(B)DLC
PTPDLC Polyurea Thirsty Pear drop breath smells (ketones) (B) Deep breathing Lethargic Confusion
LUC, DKA or just drunk?
DKA- checking blood sugar levels
What do you do if…
PATIENT DISPLAYS SYMPTOMS OF DKA?
BLOOD SUGAR LEVELS >11mol/L?
PATIENT DISPLAYS SYMPTOMS OF DKA? Check blood sugar levels
BLOOD SUGAR LEVELS >11mol/L? Check ketone levels
DKA- ketone levels
- 6-1.5mmol?
- 6-2.9mmol?
3mmol?
- 6-1.5mmol? slight risk (retest in 2hrs)
- 6-2.9mmol? increased risk (contact GP)
3mmol? medical emergency
DKA- TREATMENT
BP<90?
Once BP>90? Give…
Start IV insulin mixed w/ NaCl, administer at a rate so that
ketone conc. falls at?
blood glucose conc. falls at?
BP<90? RESTORE VOLUME W/ 500ml IV NaCl 0.9%
Once BP>90? GIVE MAINTENANCE IV NaCl 0.9%
Start IV soluble human insulin! mixed w/ NaCl, administer at a rate so that…?
- ketone conc. falls at 0.5mmol/L/hr
- Blood glucose conc/ falls at 3mmol/L/hr
DKA- TREATMENT
What do you do when blood glucose <14mmol/L?
Continue insulin till..
ketone<
ph>?
When patient is able to eat, give…?
Finally, stop treatment…?
What do you do when blood glucose <14mmol/L? Give IV glucose 10%
Continue insulin till..
ketone <3 mmol/L
&
pH>7.3
When patient is able to eat, give fast-acting insulin w/ meal
Finally, stop treatment 1hr after food
INSULIN DURING SURGERY
ELECTIVE (minor w/ good glycaemic control) day before?
ELECTIVE (minor w/ good glycaemic control) day before? Reduce OD long-acting dose by 20%, rest as usual
INSULIN DURING SURGERY
ELECTIVE (major/poor glycaemia control)
DAY BEFORE?
ON THE DAY?
DAY BEFORE?
Reduce long-acting dose by 20%- rest as usual
ON THE DAY?
- Reduce long-acting dose by 20%- stop other insulin till patient eating
- IV infusion of KCL+Glucose+NaCl
- Variable rate IV insulin (soluble human)
- Hourly blood glucose measurements for first 12hrs
- Give IV glucose 20% if blood glucose dips <6mmol/L
INSULIN- POST SURGERY
When do you convert back to SC insulin?
BASAL-BOLUS REGIMEN?
CONVERT BACK TO SC INSULIN when patient can eat/drink
Restart B-B with the first meal- IV insulin infusions carried on till 30-60mins after first meal-time short-acting insulin dose
INSULIN- POST SURGERY
LONG-ACTING REGIMEN?
Carry on at 80% until patient leaves hospital
INSULIN- POST SURGERY
BD REGIMEN?
Restart before breakfast/evening meal- IV insulin infusion carried on for 30-60mins after first SC insulin dose
SICK DAY RULES
SUGAR LEVELS?
INSULIN?
CARBOHYDRATES?
KETONES?
SUGAR LEVELS? Check regularly
INSULIN? Carry on taking
CARBOHYDRATES? Keep eating+stay hydrated
KETONES? Check regularly
DIABETES- PREGNANCY/BREASTFEEDING
Risks to woman+foetus, risk reduced by effective blood-glucose control
DIABETES- PREGNANCY/BREASTFEEDING
PLANNING FOR PREGNANCY?
Aim for HbA1c< 48mmol/mol
Take folic acid 5mg
FOLIC ACID
HIIGH RISK OF NEURAL TUBULE DEFECTS?
diabetes, antiepileptics, previous yute, smoking is just at risk factor, relax
5MG OD
BEFORE CONCEPTION+TILL WEEK 12 PREGNANCY
SICKLE CELL THROUGHOUT
FOLIC ACID
LOW RISK OF NEURAL TUBULE DEFECTS?
400MCG OD
BEFORE CONEPTION+TILL WEEK 12 PREGNANCY
WOMEN TAKING INSULIN MUST BE AWARE OF..?
HYPOGLYCAEMIA RISK
+
ALWAYS CARRY FAST-ACTING GLUCOSE
DIABETES- PREGNANCY/BREASTFEEDING
x3 MEDICATION KEY POINTS?
- Stop all antidiabetics, bar metformin.
- 1st line long-acting insulin: isophane insulin*
- Statins/ACE-i/ARBs-> discontinue
*Good blood glucose control before pregnancy w/ long-acting insulin analogues (detemir/glargine) calm to continue
GESTATIONAL DIABETES
Developed during pregnancy, STOP treatment after birth
GESTATIONAL DIABETES
Fasting BG<7mmol/L?
- Diet+Exercise. L?
- Metformin (unlicensed). L?
- Insulin
IF REQUIREMENTS NOT MET IN 1-2 WEEKS!
GESTATIONAL DIABETES
Fasting BG>7mmol/L?
diet, exercise, insulin and MAYBE metformin
no longer glinbeclamide!
GESTATIONAL DIABETES
Fasting BG 6-6.9mmol/L w/ complications?
macrosomia- newborn»»> than average
hydramnios-»_space;»>amniotic fluid build up
Insulin
with/without Metformin
HYPOGLYCAEMIA- mmol/L?
<4mmol/L
HYPOGLYCAEMIA- SYMPTOMS?
SWEATING LETHARGIC DIZZINESS HUNGER TREMOR TINGLING LIPS PALPITATIONS EXTREME MOODS PALE
HYPOGLYCAEMIA- TREATMENT (conscious+can swallow)
with/without symptoms!
What 3 things could you give?
FAST-ACTING CARBS:
- 4-5 glucose tablets
- 3-4 heaped teaspoonfuls of sugar
- 150-200mL fruit juice
- Repeat/ 15mins for 3 cycles
HYPOGLYCAEMIA- TREATMENT (patient unconscious/swallow L)
What do you do now?
IV glucagon
unresponsive after 10mins?
IV glucose
Why be careful with b-blockers?
Can mask the effects of hypoglycaemia
OSTEOPOROSIS
What is it?
Progressive bone disease- reduction of bone mass+density, causing increased risk of fractures
RISK FACTORS FOR OSTEOPOROSIS?
POSTMENOPAUSAL WOMEN MEN>50 LONG-TERM ORAL CORTICOSTEROIDS (glucocorticoids) Age increase Vitamin D+Calcium deficiency Lack of exercise Low BMI Smoking+drinking History of fractures Early menopause
LIFESTYLE CHANGES?
Increase exercise Smoking cessation Maintain an ideal BMI Reduce alcohol intake Increase intake of vitamin D+calcium (supplement if need be)
OSTEOPOROSIS- TREATMENT
Review need for medication after how many years?
After 5 years for most meds, 3 years for Zoledronic
OSTEOPOROSIS- TREATMENT
1st LINE?
ORAL BISPHOSPHONATES (alendronic acid/risedronate sodium)
OSTEOPOROSIS- TREATMENT
POSTMENOPAUSAL?
POSTMENOPAUSAL? ibandronic acid/denosumab/raloxifene/strontium
OSTEOPOROSIS- TREATMENT
YOUNGER MENOPAUSAL WOMEN?
USE HRT/TIBOLONE
OSTEOPOROSIS- TREATMENT
TERIPARATIDE- used in severe osteoporosis
OSTEOPOROSIS TREATMENT
MEN?
ZOLENDRONIC ACID
DENOSUMAB
TERIPARATIDE
STRONITUM
OSTEOPOROSIS TREATMENT
GLUCOCORTICOID-INDUCED?
FIRST LINE
ALENDRONIC ACID/RISEDRONATE
ZOLEDRONIC ACID
DENOSUMAB
TERIPARATIDE
GLUCOCORTICOID-INDUCED OSTEOPOROSIS
Bone-protection treatment, considered in everyone on large dose corticosteroids for how many months?
> 3 months
GLUCOCORTICOID-INDUCED OSTEOPOROSIS
WOMEN- RISK FACTORS?
> /= 70 years
Previous fragility fracture
Large doses of glucocorticoids (>/= prednisolone 7.5mg OD)
GLUCOCORTICOID-INDUCED OSTEOPOROSIS
MEN- RISK FACTORS?
> /= 70 years AND either:
Previous fragility fracture
OR
Large doses of glucocorticoids
BISPHOSPHONATES- MHRA WARNINGS?
ATYPICAL FEMORAL FRACTURES- thigh/hip/groin pain
OSTEONECROSIS OF THE JAW- dental pain/swelling/non-healing sores/discharge
OSTEONECROSIS OF THE EXTERNAL AUDTIORY CANAL- report ear pain/discharge/ear infection
BISPHOSPHONATES- SIDE-EFFECTS
OSEOPHAGEAL REACTIONS,
REPORT & STOP?
How do you avoid oesophageal reactions?
REPORT & STOP for: oesophageal irritation, dysphagia & heartburn
How do you avoid oesophageal reactions? Take w/ FULL GLASS OF WATER SITTING/STANDING EMPTY STOMACH AT LEAST 30MINS BEFORE BREAKFAST SIT UP RIGHT/STAND 30MINS AFTER
ALENDRONIC ACID^
RISEDRONATE COUNSELLING?
TAKE 30MINS BEFORE BREAKFAST
OR
LEAVE 2 HOURS BEFORE & AFTER FOOD/DRINK AT OTHER TIME OF DAY
SEX HORMONE RESPONSIVE CONDITIONS
2 TYPES OF OESTROGENS?
NATURAL- estradiol, estrone & estriol
SYNTHETIC- ethinylestradiol & mestranol
PROGESTOGENS? NLD
NORETHISTERONE
LEVONORGESTREL
DESOGESTREL
TIBOLONE ACTIVITY?
OESTROGENIC
PROGESTOGENIC
WEAKLY ANDROGENIC
HORMONE REPLACEMENT THERAPY
What menopausal symptoms can oestrogen alleviate?
itching, flushing, burning
can reduce postmenopausal osteoporosis
HORMONE REPLACEMENT THERAPY
Issue with Clonidine?
Can be used for vasomotor symptoms, BUT
large side-effect profile
HORMONE REPLACEMENT THERAPY- RISKS
BREAST CANCER?
Increased risk after 1 year
Risk higher in combined HRT over oestrogen-only
Excess risk persists for >10 years after stopping
but risk lowers after stopping
HORMONE REPLACEMENT THERAPY- RISKS
ENDOMETRIAL CANCER?
Women with uterus-
Lower risk in combined HRT than oestrogen-only
Tibolone also increases risk
HORMONE REPLACEMENT THERAPY- RISKS
OVARIAN CANCER?
Small increase which disappears a few years after stopping
HORMONE REPLACEMENT THERAPY- RISKS
VTE?
Increased risk of DVT with both oestrogen-only & combined HRT
Increased risk with prolonged bed rest, obesity, trauma & family history
HORMONE REPLACEMENT THERAPY- RISKS
STROKE?
Slight increase w/ both oestrogen-only & combined HRT
Tibolone increases risk by x2.2 in first year of treatment
HORMONE REPLACEMENT THERAPY- RISKS
CORONARY HEART DISEASE?
Increased risk in combined HRT when started >10 years after menopause
CHOOSING HRT
WOMEN W/ UTERUS?
Oestrogen w/ cyclical progestogen for last 12-14 days of the cycle
OR
Continuous administration of an oestrogen+progestogen (from day 1)
NOTE: Continuous combined+tibolone, avoid in perimenopausal phase(just before menopause)/within 12months of last menstrual period
CHOOSING HRT
WOMEN WITHOUT UTERUS?
WHAT DO YOU DO IF ENDOMETRIOSIS OCCURS?
CONTINUOUS OESTROGEN USE
Endometriosis? Add progesterone
HRT- SURGERY
ELECTIVE
When do you stop HRT?
When do you reinitiate?
STOP HRT 4-6 WEEKS BEFORE SURGERY
REINITIATE WHEN FULLY MOBILE
HRT- SURGERY
NON-ELECTIVE?
PROPHYLACTIC HEPARIN
GRADUATED COMPRESSION STOCKINGS
REASONS TO STOP HRT?
SUDDEN CHEST PAIN/BREATHLESSNESS (pe?) SWELLING/SEVERE PAIN IN CALF (dvt) SEVERE STOMACH PAIN (hepatoxicity) NEUROLOGICAL: prolonged headache, fainting, seizures HEPATITIS/JAUNDICE BP> 160mmHg systolic OR 95mmHg diastolic PROLONGED IMMOBILITY
THYROID HORMONES- negative feedback loop?
High levels of T3+T4->low levels of TSH->inhibits own production
High levels of T3+T4->low levels of TSH->inhibits own production
HYPERTHYROIDISM LEVELS?
LOW TSH-> HIGH T3+T4, too much thyroid hormone
HYPERTHYROIDISM
SYMPTOMS?
HYPERACTIVITY INSOMNIA HEAT INTOLERANCE INCREASED APPETITE WEIGHT LOSS DIARRHOEA GOITRE
HYPERTHYROIDISM- TREATMENT
1st LINE?
2nd LINE?
1st LINE? CARBIMAZOLE
2nd LINE? PROPYLTHIOURACIL
HYPERTHYROIDISM
CARBIMAZOLE MHRA WARNINGS? CM-NAP
Neutropenia+Agranulocytosis-> sore throat, malaise, fever
Congenital Malformations-> use effective contraception
Acute Pancreatitis-> report & stop ASAP (severe abdominal pain, GLP-1s & flozins ;) )
Note: B-blockers can be used for symptomatic relief in primary hyperthyroidism
HYPERTHYROIDISM
PROPYLTHIOURACIL cautioned in..?
Cautioned in liver disorder-> jaundice, dark urine, nausea
Note: B-blockers can be used for symptomatic relief in…
PRIMARY HYPERTHYROIDISM
HYPERTHYROIDISM- TREATMENT
GRAVE’S DISEASE
1st LINE?
RADIOACTIVE IODINE
But if remission is likely with anti-thyroids, consider carbimazole
Iodine/surgery unsuitable? Consider carbimazole
Given as a block & replace regimen in combo w/ levyothyroxine for 12-18 months
HYPERTHYROIDISM- TREATMENT
PREGNANCY
1st TRIMESTER?
2nd+3rd TRIMESTER?
1st TRIMESTER? Propylthiouracil (>carbimazole’s congenital defects)
2nd+3rd TRIMESTER? Carbimazole (>propylthiouracil’s hepatotoxicity)
HYPOTHYROIDISM LEVELS?
HIGH TSH->LOW T3+T4
HYPOTHYROIDISM
SYMPTOMS?
FATIGUE WEIGHT GAIN CONSTIPATION DEPRESSION DRY SKIN INTOLERANCE TO COLD MENSTRUAL IRREGULARITIES
REDUCED METABOLIC ACTIVITY!
HYPOTHYROIDISM- TREATMENT
1st LINE?
LEVOTHYROXINE
HYPOTHYROIDISM- TREATMENT
LEVOTHYROXINE
Monitor TSH/?
How to take it?
Brands?
Monitor TSH/? /3 months till stable, then yearly thereafter
How to take it? Take medicine in AM, at least 30mins before brekky/red bull
Brands? Some patients can feel symptoms if alternating between brands
HYPOTHYROIDISM TREATMENT
LIOTHYRONINE?
Rare
More rapid+potent (20-25mcg= 100mcg levo)
Non-UK brands may not be bioqeuivalent
INTERMEDIATE INSULIN EXAMPLES?
ISOPHANE
INSULTARD
HUMULIN I
NOT INTERMEDIATE?
TRESIBA- DEGLUDEC- LONG-ACTING
METFORMIN
AVOID IF eGFR is LESS THAN?
30 mL/minute/1.73 m2
POTASSIUM LOSS
HYPERTENSION
WATER RETENTION
?
MINERALCORTICOIDS
DIABETES
OSTEOPOROSIS
PEPTIC ULCERATION
?
GLUCOCORTICOIDS
Miss A is 27 years old and has type 1 diabetes. Her PMR shows that she uses NovoRapid (insulin aspart) and Lantus (insulin glargine). Which of the following is/are appropriate if she experiences severe diarrhoea and is unable to eat solid foods? She should
Increase the frequency of blood glucose monitoring, Take oral rehydration therapy
FASTING BLOOD GLUCOSE ON WAKING?
5-7
DIABETIC MEDICATION CONTRAINDICATED IN
HEART FAILURE
BLADDER CANCER?
PIOGLITAZONE
DIABETIC KETOACIDOSIS RISK?
FLOZINs
GLIPTINs (not lina or saxo!)
GLP-1 (NOT dulaglutide)
Absolute L when insulin abruptly stopped
GLICLAZIDE/SULPHONYLUREA ELDERLY?
Elderly
Prescription potentially inappropriate (STOPP criteria) if prescribed a long-acting sulfonylurea (e.g. glibenclamide, chlorpropamide, glimepiride) in type 2 diabetes mellitus (risk of prolonged hypoglycaemia).
SICK DAY RULES?
Just because the patient is ill and not eating does not mean they should stop injecting their insulin
ill/ infection= stress hormones/ steroids released
steroids increase blood glucose
stay well hydrated to avoid DKA
patient should monitor their BG and urine ketones more frequently and be prepared to inject accordingly
A trainee pharmacist asks you to go through the different types of studies conducted in research in order to
produce reliable evidence.
Which of the following studies is most likely to produce reliable results?
o Systematic Reviews
Patient, flushing, face, what med?
CCB, amlodipine
A 2-month-old boy has been admitted to hospital with suspected bacterial meningitis
Which is the most appropriate treatment for this patient?
BENZYL-CEFOTAXIME-CHLORAMPHENICOL
SITAGLIPTIN DOSE ADJUSTMENT RENAL?
50mg OD if eGFR 30–45 mL/minute/1.73 m2.
25mg OD if eGFR less than 30 mL/minute/1.73 m2.
CUTANEOUS DD LIPOHYERP
INSULIN TYPE 1 FIRST LINE?
insulin detemir twice daily and insulin aspart before meals
BASAL-BOLUS!
chlorhexidine, gingivitis?
taste disturbance
METFORMIN PATIENT ADVICE?
risk of lactic acidosis and told to seek immediate medical attention if symptoms such as dyspnoea, muscle cramps, abdominal pain, hypothermia, or asthenia occur.
METRONIDAZOLE BV DOSING?
400–500 mg twice daily for 5–7 days, alternatively 2 g for 1 dose
DIABETIC CHOC, NOT ENOUGH SUGAR!
CO-AMOX HEPATOXIC!
monitor insulin more when meal times changed
One week after his hospital admission, the patient develops diarrhoea. A stool sample confirms
the presence of Clostridium difficile infection. Doctors decide to stop the lansoprazole and review
the antibiotic for his infection.
Which ONE of this patient͛s medications listed below is MOST likely to require temporary
discontinuation in view of his Clostridium difficile infection?
stop ibu he’s sick
BISPHOSPHONATES COUNSELLING
ALENDRONIC ACID?
RISEDRONATE?
alen- avoid if crcl<35
rised- avoid if crcl<30
type 1 diabetes, high sugars, too much ketones- abdominal pain!
not flatulence? hm
VILDGALIPTIN, HEPATOTOXIC!!
ABRUPT INSULIN STOP- DKA risk?
ALL THE GLP1s
but dulalglutide not contraindicated in ketoacidosis, don’t get it twisted!
PIOGLITAZONE AVOID IN?
BONE FRACTURES LIVER TOXICITY- report N&V, abdominal pain, fatigue & dark urine HF BLADDER CANCER BONE FRACTURES
HOW OFTEN DO YOU MEASURE HBA1C?
type 1 diabetes- 3 to 6 months, and more frequently if blood-glucose control is thought to be changing rapidly.
type 2 diabetes- 3 to 6 months until HbA1c and medication are stable when monitoring can be reduced to every 6 months. STABLE 6 MONTHS
what is exenatide?
GLP-1 mate
Binds to, and activates, the GLP-1 (glucagon-like peptide-1) receptor to increase insulin
secretion, suppresses glucagon secretion, and slows gastric emptying.
DIARRHOEA IN HRT?
myna
MINERALCORTICOID SIDE-EFFECTS?
hypertension sodium retention water retention hypokalaemia hypocalcaemia
BG TARGET WHILST DRIVING?
> 5 AT LEAST
Mr rue Licitiy is a new patient at your practice. You are conducting a new patient meds
reconciliation and review with the patient. From his previous practice records you note that
he is a Type 2 Diabetic, who is stable on Metformin, Gliclazide and Dapagliflozin. You have a
look at his previous HbA1cs and can see that it is stable, around 52mmol/mol.
How often should Mr Prue Licitiy get his HbA1c checked?
Every 6 months
trulicity drug?
dulaglutide
cvd DIABETES COMPLICATION?
MACRO!
AWARENESS OF HYPOGLYCAEMIA SYMPTOM?
GOLD SCORE
MONITORING TSH LEVELS?
/3 months till stable, then yearly thereafter
YEARLY ONCE STABLE
You are discussing anti-diabetic treatment regimes for type 2 diabetes with a fellow
colleague. Your colleague has a question regarding ongoing use of GLP-1 mimetics once
initiated in a patient.
Which one of the following statements below is an accurate representation of when
GLP-1 mimetics should be continued to treat Type 2 diabetes?
Patient has a reduction of at least 3% initial body weight and 1% reduction of Hb1Ac
within 6 months
GLP1 FACT
If triple therapy with metformin and 2 other oral drugs is not effective, not tolerated or contraindicated,
consider triple therapy by switching one drug for a GLP-1 mimetic for adults with type 2 diabetes who:
• have a body mass index (BMI) of 35 kg/m2 or higher (adjust accordingly for people from Black,
Asian and other minority ethnic groups) and specific psychological or other medical problems
associated with obesity or
• have a BMI lower than 35 kg/m2 and:
– for whom insulin therapy would have significant occupational implications or
– weight loss would benefit other significant obesity related comorbidities.
You are reviewing a clinic letter from the consultant endocrinologist for Mr P 29-years-old.
The consultant has recommended initiating a “block and replace” treatment regimen to help
treat his hyperthyroidism.
Usually how long would you expect this “block and replace” regimen to be given?
18 months, thought it was 12-18?
AKI likely presentation? Mad word
Oliguria
Oliguria is the production of abnormally small amounts of urine. It is one of the symptoms of AKI
alongside oedema (legs, ankles and around the eyes), fatigue, shortness of breath, confusion,
nausea, seizures, chest pain or pressure and coma (severe)
Mr H has a diagnosis of Type 2 diabetes from a few months ago. He has been finding it very
difficult to control his glucose levels. The doctor has decided to start him on a new antidiabetic drug. Mr H is a bus driver and is concerned that this new medication will affect his
ability to drive. When counselling Mr H, you tell him that he can drive but should be wary of
hypoglycaemia and should try and avoid it.
Which of the following medications has Mr H most likely been started on?
Glipizide is a sulfonylurea and they are known to cause hypoglycaemia. They act mainly by
augmenting insulin secretion and consequently are effective only when some residual pancreatic
beta-cell activity is present
Mrs N is a 52year old woman who is suffering from the symptoms of menopause. She also
has asthma and hyperthyroidism. She is on the following medication:
● Carbimazole 5mg OD
● Alendronic acid 70mg weekly
● Adcal D3, TWO tablets TWICE daily
● Salbutamol 100mcg, TWO puffs when required
● Seretide 125 evohaler, TWO puffs BD
Mrs N presents at the pharmacy with symptoms of heartburn and difficulty swallowing.
Which one of Mrs S’ medications is the most likely cause of her symptoms?
ALENDRONIC ACID
Severe oesophageal reactions are a side effect of oral bisphosphonates. Severe Oesophageal
reactions (oesophagitis, oesophageal ulcers, oesophageal stricture and oesophageal erosions)
have been reported; patients should be advised to stop taking the tablets and to seek medical
attention if they develop symptoms of oesophageal irritation such as dysphagia, new or
worsening heartburn, pain on swallowing or retrosternal pain.
diabetic neuropathy
foot infection?
refer to foot protection service, not gp
ciprofloxacin+ibuprofen?
IV meropenem L too
reduces seizure threshold!!
A patient has suspected unstable angina and a glyceryl trinitrate spray is ineffective.
Manage?
ASPIRIN 300MG P
ORLISTAT+LEVOTHYROXINE?
THYROID, INTERACTION, CHECK
Signs of meningitis. 1st line is benzylpenicillin but unsuitable due to penicillin allergy.
Cefotaxime can be used as no history of immediate anaphylactic reaction to penicillins.
See a doctor first
WHAT DRUG RISK OF LOWER LIMB AMPUTATION?
CANAGLIFLOZIN!
INSULIN PEN
METFORMIN, LESS B12, AVOID IF CRCL IS
30ml/min
SULPHONYLUREAS should be avoided in?
Hepatic and renal failure
PIOGLITAZONE avoid in?
HF
bladder cancer
bone fractures
liver toxicity
DPPis
Pancreatitis?
Hepatotoxic?
DPPis
Pancreatitis? Alogliptin Linagliptin Sitagliptin Saxagliptin Vildagliptin
Hepatotoxic?
Vildagliptin
SGLT2s monitor renal function?
CANAGLIFLOZIN- ‘LLA’ ;)
DAPAGLIFLOZIN
EMPAGLIFLOZIN
GLP-1 AGONIST
PANCREATITIS?
DULAGLUTIDE
EXENATIDE
LIRAGLUTIDE
LIXISENATIDE
SC INSULIN REGIMEN, SURGERY, doesn’t require?
IV infusion continued 1hr later?
SIDE-EFFECTS OF INSULIN?
WEIGHT GAIN
OEDEMA (reabsorption of soidum, water, etc)
LIPODYSTROPHY- body storing fat,
SKIN REACTIONS
NOT WEIGHT LOSS
(hypertrophy- lump of fat tissue under skin, repeated injection)
Patient w/ lipodystrophy/cutaneous amyloidosis?
NO NEED TO REFER
Just rotate injection sites
gluconeogenesis?
the production of glucose
DRUG TO PRESCRIBE BY BRAND?
NIFEDIPINE MR
medication hyperglycaemia risk?
thiazide, bendro
Novorapid advice?
Generally taken before a meal.
Taken immediately before a meal due to risk of hypo, onset of action is <15mins!
NOVORAPID ADMINISTRATION?
Rapid acting, immediately at/before
but also after eating, wow
ultra rapid acting insulin?
Fiasp, right at meal, woi
15mins before meal insulin?
short-acting insulins bovine porcine insuman rapid humulin s actrapid
INSULATARD? LYUMJEV? TOUJEO? TRESIBA? ACTRAPID?
INSULATARD? isophane, intermediate LYUMJEV? lispro, rapid-acting TOUJEO? glargine, long-acting TRESIBA? degludec, long-acting ACTRAPID? short-acting
RAPID-ACTING INSULINS?
LISPRO- HUMALOG
ASPART- NOVORAPID
GLULISINE- APIDRA
SHORT-ACTING INSULINS? SOLUBLE/NEUTRAL
ACTRAPID HUMULIN S INSUMAN RAPID BOVINE NEUTRAL PORCINE NEUTRAL
INTERMEDIATE-ACTING INSULINS? ISOPHANE
BOVINE ISOPHANE PORCINE ISOPHANE INSULATARD HUMULIN I INSUMAN BASAL
LONG-ACTING INSULINS?
DETEMIR- LEVEMIR
DEGLUDEC- TRESIBA
GLARGINE- LANTUS
BIPHASIC INSULINS- BIPHASIC INSULIN ASPART?
NOVOMIX 30
WHAT IS USED TO TREAT ADDISON’S DISEASE/ADRENAL INSUFFICIENCY?
HYDROCORTISONE… PRIMARY+FLUDROCORTISONE
SIDE-EFFECTS OF CORTICOSTEROID USE?
DIABETES
OSTEOPOROSIS
WEIGHT GAIN
MUSCLE WASTAGE
NOT ADDISON’S DISEASE, IT TREATS IT!
FIASP?
insulin aspart+nicotinamide- vitamin b3
BIPHASIC INSULINS- BIPHASIC INSULIN LISPRO?
HUMALOG MIX25
HUMALOG MIX50
BIPHASIC INSULINS- BIPHASIC ISOPHANE?
HUMULIN M3
INSUMAN COMB 15
INSUMAN COMB 25
INSUMAN COMB 50
An 82-year-old patient has been newly diagnosed with type 2 diabetes mellitus. Their past
medical history includes atrial fibrillation, previous bladder cancer and hypertension. Recent
blood results show an eGFR of 25 mL/min.
Which Of the following would be the most appropriate initial drug therapy for this patient?
A. Dapagliflozin
B. Glibenclamide
C. Metformin
D. Pioglitazone
E. Sitagliptin
Dapagliflozin- consider additional antidiabetic if egfr <45
Sitagliptin- 25mg OD egfr<30
HRT RISKS?
BREAST CANCER
NOT? OSTEOPOROSIS
METFORMIN MAX./DAY?
2G
Metformin is available in a selection of strengths and formulations. Which Of the following is NOT an
appropriate dose of metformin?
A. Metformin 500mg tablets. ONE tablet taken each day with breakfast for at least one week for an
adult newly diagnosed with type 2 diabetes
B. Glugophage SR 1000mg tablets. TWO tablets taken daily with evening meal for an adult male
with type 2 diabetes
C. Metformin 500mg tablets. TWO tablets taken with breakfast and TWO with evening meal for an
adult female with polycystic Ovary Syndrome
D. Metformin hydrochloride 100mg/ml oral solution sugar free. ONE 5ml spoonful taken three
times a day for a 13-year-old child with type 2 diabetes
E. Metformin 500mg tablets. TWO tablets taken three times a day for a 29-year-Old pregnant
woman with gestational diabetes
E- too much relax
A diabetic patient is having his insulin regime reviewed with his diabetic nurse. He is prescribed an
insulin he has never used before. He presents in your pharmacy with a prescription for Insulin lispro.
Which Of the following products is correct?
A. Lantus
B. Levemir
C. Novorapid
D. Apidra
E. Humalog
Humalog- insulin lispro
A patient has a review at the diabetes clinic and a decision is made to begin a basal insulin
regime. Due to his current social situation, it is decided that the prescribed insulin should be
chosen in order that the carer can remind the patient to administer the insulin once daily around
breakfast time. Which of the below insulins would be the most appropriate to prescribe?
A. Apidra (insulin glulisine)
B. Humulin S (soluble insulin)
C. Humalog (insulin lispro)
D. Novomix 30 (biphasic insulin aspart)
E. Tresiba (insulin degludec)
Tresiba, insulin degludec
Mr R, aged 76, is diagnosed with type 2 diabetes and osteoarthritis and has been prescribed
the medicines listed below. He lives alone but has a carer visit twice a day to help around the
house.
Mr R’s carer visits your pharmacy to ask for advice. She tells you he is suffering from “sickness
and diarrhoea and hasn’t been able to keep anything down”. You are worried about these
symptoms and decide to advise the patient to withhold one of his regular medications. Which
one of the following would it be most appropriate for Mr R to withhold?
A. Atorvastatin
B. Codeine
C. Lantus Solostar (insulin glargine)
D. Metformin
E. Paracetamol
D, METFORMIN
SICK DAYS
SADMAN, stop, come on
The diabetes clinic counsels Mr R regarding recognising the symptoms of hypoglycaemia and diabetic ketoacidosis. Which one of the following is least likely to be a symptom of hypoglycaemia? A. Blurred vision B. Bradycardia C. Mood changes D. Sweating E. Tremor
NOT BRADYCARDIA
After a recent HbA1c test, a diabetes nurse decides to prescribe canagliflozin for Mr
R. He comes into the pharmacy two weeks later, with conjunctivitis in one of his eyes and
wonders if his new rnedication may increase the risk of eye infections. Which is the most
appropriate response?
A. Canagliflozin is a black triangle drug and all adverse effects should be reported via
the Yellow Card Scheme
B. Eye infections are not a known side effect of canagliflozin. Mr R could treat his
conjunctivitis with chloramphenicol eye drops
C. Eye infections are a known side effect of canagliflozin. Mr R should continue taking
the canagliflozin but if the eye infections become recurrent, he could return to his
diabetes nurse for an alternative
D. Eye infections are a known side effect of canagliflozin. Mr R should continue taking
the canagliflozin and see his GP
E. Eye infections are a known side effect of canagliflozin. Mr R should stop taking the
canagliflozin and see his GP
B, unknown, chloramphenicol myna
side-effects of glucocorticoids?
growth retardation hypertension hyperglycaemia osteoporosis weight gain
not hypoglycaemia,silly, read Q, eliminate and execute
STEROID WITHDRAWAL, KEY TERM
more than PREDNISOLONE 40MG OR EQUIVALENT AND….?
MORE THAN 40MG OD FOR MORE THAN A WEEK, SO 7 DAYS IS FINE, key details
A drug, hypocalcaemia risk?
Denosumab
MHRA/CHM advice: Denosumab: minimising the risk of osteonecrosis of the jaw; monitoring for hypocalcaemia
HYPOGLYCAEMIA YOU ARE TACHYCARDIC
Driving 45 mins after?
Blood glucose level is normal, NOT after eating
Informing DVLA, gestational?
Need insulin for >3 months after birth
Acne, lowest photosensitivitiy risk? highest?
Lowest- Minocycline
Highest- Doxy/Oxy
hba1c monitoring?
3-6 months
type 2 stable, 6 months
HbA1c should usually be measured in patients with type 1 diabetes every 3 to 6 months, and more frequently if blood-glucose control is thought to be changing rapidly. Patients with type 2 diabetes should be monitored every 3 to 6 months until HbA1c and medication are stable when monitoring can be reduced to every 6 months.
osteoporosis+prednisolone L
osteoporosis+prednisolone L
SITALGLIPTIN INTERSTITIAL LUGN DISEASE? OK
HBA1C TARGETS?
48 IF NO hypoyglycaemia drugs
53 IF HYPOYGLYCAEMIA DRUGS
Mr H, a 45-year old patient at your community pharmacy, brings in a new prescription for linagliptin
5 mg tablets once daily. You notice that he was previously prescribed sitagliptin 100 mg tablets once
daily, which he had been taking for 2 years. Mr H has type 2 diabetes mellitus which is currently well
controlled. Mr H’s only Other regular medication is ibuprofen 400 mg tds for back pain.
Which of the following is the most likely reason for the switch to linagliptin?
The patient’s renal function has deteriorated and so linagliptin is more appropriate
A diabetic patient is having his insulin regime reviewed with his diabetic nurse. He is prescribed an
insulin he has never used before. He presents in your pharmacy with a prescription for Insulin lispro.
Which Of the following products is correct?
HUMALOG LISPRO!!!
NOVORAPID ASPART!!!!
GLULISINE APIDRA!!
FLOZIN, REDUCED RENAL?
CONSIDER ADDITIONAL DRUG
GLIPTIN BEST
BRADYCARDIA NOT A SYMPTOM OF?
HYPOYGLYCAEMIA!
SUGAR HYPO?
DISSOLVED IN WATER!
Mr. AJ is a 19-year-old newly diagnosed with type-1 diabetes. Which of the
following is recommended as first-line therapy?
BASAL-BOLUS FIRST LINE!
BD INSULIN DETEMIR
INSULIN DEGLUDEC- nocturnal hypoglycaemia
DEGLUDEC/GLARGINE- once daily, carer/ etc
levothyroxine dose?
25mcg before food
Anaemia can exacerbate heart failure!!
WHAT IS NOT RECOMMENDED IN TRIPLE THERAPY?
DAPAGLIFLOZIN+PIOGLITAZONE
In type 1 diabetes, aim for a clinic blood pressure of 135/85 mmHg or less unless the adult with type 1 diabetes has albuminuria or 2 or more features of metabolic syndrome, in which case it should be 130/80 mmHg or less